To a certain extent small is our niche, too small for the big boys to worry about. We also have the scope to prove up something bigger if luck is with us.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025